# 36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds

> **NCT00728260** · — · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 1421 (actual)

## Conditions studied

- Meningitis
- Meningococcal Disease

## Interventions

- **BIOLOGICAL:** None administered in this study

## Key facts

- **NCT ID:** NCT00728260
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 1421 (ACTUAL)
- **Last updated:** 2015-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00728260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00728260, "36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00728260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*